Announcing the addition of Dr. Jan Suchodolski to the Anubis Bio Advisory Team

30Jun

Announcing the addition of Dr. Jan Suchodolski to the Anubis Bio Advisory Team

Portfolio News
Anubis Bio, the parent company behind DoggyStat, the first product of its kind to use passive immunity to treat canine diarrhea, announced today the addition of Dr. Jan Suchodolski (MedVet, DrVetMed, Ph.D., AGAF, DACVM) to the company’s Advisory Team. Read more >>

Share this post

Related Posts

02Jan

AL HAMNIK: Shedding light on life’s challenges

Scott Reese had sent a letter to Canadian-based eSight, telling his story of endless challenges and ordeals. To his surprise,... read more
23Aug

From the US to EU, how EcoSoul Home clocked over Rs 100 cr in GMV by exporting sustainable products

Launched in August 2020, eco-friendly home essentials brand EcoSoul Home aims to accelerate the movement towards a sustainable lifestyle by... read more
06Jan

Regroup Mass Notification Wins 2020 Unified Communications Product of the Year Award

Regroup Mass Notification, a trusted provider of emergency and day-to-day communication solutions, today announced that it has been chosen by... read more
27Apr

US fishmeal substitute player inks process collaboration deal

KnipBio and ICM have agreed a joint effort to work on a commercial-scale fermentation process for the biotech company's premium... read more
29Jun

Why Partnering Is The Key To Innovative Engineering Software

A Product Lifecycle Management (PLM) software company, Aras Corporation, tapped AMC Bridge to help develop a modern visualization tool for... read more
08Mar

Candidly picks up student debt relief where new US policies leave off

While some fintech companies have taken the borrower approach, others are looking at it from an employee benefit perspective and... read more
24Nov

A Wearable Tech Miracle For the Legally Blind

For Conrad Lewis, the founder of eSight, the project is close to the heart. Lewis grew up with two legally... read more
25Feb

SCBIO caps annual conference in Charleston with $5,000 pitch competition

To close out the SCBIO 2023 conference, three South Carolina early startups in the life sciences industry pitched venture capitalists... read more
30Sep

Commercial breakthrough for fishmeal alternative

KnipBio has received order for several tonnes of its innovative fishmeal alternative, KnipBio Meal (KBM). Read more >> read more
09Mar

Corbus Pharmaceuticals to Present Gene Expression Data from Recent Phase 2 Systemic Sclerosis Study Demonstrating JBT-101 Inhibits Inflammation and Fibrosis Pathways

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious... read more